https://www.nxtpsychedelics.com/news/articles/psychedelics/atma-welcomes-dr-scott-shannon-maps-mdma-phase-3-principal-investigator-to-expand-its-clinical-training-expertise-in-mdma-assisted-therapy/
ATMA Welcomes Dr. Scott Shannon, MAPS MDMA Phase 3 Principal Investigator, to Expand Its’ Clinical Training Expertise in MDMA-Assisted Therapy